Get started
ASTRAZENECA PLCASTRAZENECA PLCASTRAZENECA PLC

ASTRAZENECA PLC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

AZN1/N chart


Full chart

Key facts today

AstraZeneca's Tagrisso has received European Commission approval for treating advanced non-small cell lung cancer, showing a median progression-free survival of over three years in late-stage trials.
The FDA revoked the emergency use authorization for AstraZeneca's Evusheld due to its expired shelf life and lack of patient administration approval for over a year.
Analyze the impactAnalyze the impact

AZN1/N upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.09 T‬ MXN
Dividend yield (indicated)
2.24%
Price to earnings Ratio (TTM)
36.25
Basic EPS (TTM)
87.04 MXN
Net income (FY)
‪103.58 B‬ MXN
Revenue (FY)
‪796.85 B‬ MXN
Shares float
‪1.47 B‬
Beta (1Y)
1.28

Employees


Employees (FY)
‪89.9 K‬
Change (1Y)
‪+6.4 K‬ +7.66%
Revenue / Employee (1Y)
‪8.86 M‬ MXN
Net income / Employee (1Y)
‪1.15 M‬ MXN

About ASTRAZENECA PLC ORD USD0.25


Sector
Health Technology
CEO
Pascal Soriot
Headquarters
Cambridge
Website
astrazeneca.co.uk
Founded
1992
ISIN
GB0009895292
FIGI
BBG012VHGHR8
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AZN1/N news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AZN1/N highest yielding bonds


US46353AX6
ASTRAZENECA 20/50
Yield to maturity
7.19%
Maturity date
Aug 6, 2050
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
6.54%
Maturity date
May 28, 2051
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
6.03%
Maturity date
Sep 18, 2042
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.92%
Maturity date
Nov 16, 2045
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.91%
Maturity date
Aug 17, 2048
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
5.41%
Maturity date
Sep 15, 2037
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
5.39%
Maturity date
May 28, 2031
US46353AW8
ASTRAZENECA 20/30
Yield to maturity
5.32%
Maturity date
Aug 6, 2030
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
5.19%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
5.10%
Maturity date
Mar 3, 2033
A
AZN5193317
AstraZeneca Finance LLC 1.75% 28-MAY-2028
Yield to maturity
4.98%
Maturity date
May 28, 2028

Explore more bonds 

Sparks


Curated watchlists where AZN1/N is featured.

See all sparks 

Frequently Asked Questions


The current price of AZN1/N is 3,047.68 MXN — it hasn't changed in the past 24 hours. Watch ASTRAZENECA PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ASTRAZENECA PLC stocks are traded under the ticker AZN1/N.
AZN1/N stock has risen by 0.00% compared to the previous week, the month change is a 0.00% rise, over the last year ASTRAZENECA PLC has showed a 38.75% increase.
We've gathered analysts' opinions on ASTRAZENECA PLC future price: according to them, AZN1/N price has a max estimate of 4,676.51 MXN and a min estimate of 2,716.62 MXN. Watch AZN1/N chart and read a more detailed ASTRAZENECA PLC stock forecast: see what analysts think of ASTRAZENECA PLC and suggest that you do with its stocks.
AZN1/N reached its all-time high on Dec 18, 2024 with the price of 3,047.68 MXN, and its all-time low was 2,196.58 MXN and was reached on Nov 16, 2023. View more price dynamics on AZN1/N chart.
See other stocks reaching their highest and lowest prices.
AZN1/N stock is 0.00% volatile and has beta coefficient of 1.28. Track ASTRAZENECA PLC stock price on the chart and check out the list of the most volatile stocks — is ASTRAZENECA PLC there?
Today ASTRAZENECA PLC has the market capitalization of ‪4.09 T‬, it has decreased by −0.67% over the last week.
Yes, you can track ASTRAZENECA PLC financials in yearly and quarterly reports right on TradingView.
ASTRAZENECA PLC is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
AZN1/N earnings for the last quarter are 40.98 MXN per share, whereas the estimation was 40.25 MXN resulting in a 1.83% surprise. The estimated earnings for the next quarter are 42.90 MXN per share. See more details about ASTRAZENECA PLC earnings.
ASTRAZENECA PLC revenue for the last quarter amounts to ‪267.28 B‬ MXN, despite the estimated figure of ‪257.64 B‬ MXN. In the next quarter, revenue is expected to reach ‪285.47 B‬ MXN.
AZN1/N net income for the last quarter is ‪28.96 B‬ MXN, while the quarter before that showed ‪35.42 B‬ MXN of net income which accounts for −18.23% change. Track more ASTRAZENECA PLC financial stats to get the full picture.
ASTRAZENECA PLC dividend yield was 2.15% in 2023, and payout ratio reached 73.66%. The year before the numbers were 2.13% and 138.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪89.90 K‬ employees. See our rating of the largest employees — is ASTRAZENECA PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA PLC EBITDA is ‪328.29 B‬ MXN, and current EBITDA margin is 31.31%. See more stats in ASTRAZENECA PLC financial statements.
Like other stocks, AZN1/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA PLC stock shows the strong buy signal. See more of ASTRAZENECA PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.